annual CFF:
-$1.25B-$1.24B(-10444.54%)Summary
- As of today (May 29, 2025), UTHR annual cash flow from financing activities is -$1.25 billion, with the most recent change of -$1.24 billion (-10444.54%) on December 31, 2024.
- During the last 3 years, UTHR annual CFF has fallen by -$1.30 billion (-2900.89%).
- UTHR annual CFF is now -305.30% below its all-time high of $611.20 million, reached on December 31, 2019.
Performance
UTHR Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$93.80M-$19.10M(-25.57%)Summary
- As of today (May 29, 2025), UTHR quarterly cash flow from financing activities is -$93.80 million, with the most recent change of -$19.10 million (-25.57%) on March 31, 2025.
- Over the past year, UTHR quarterly CFF has increased by +$974.20 million (+91.22%).
- UTHR quarterly CFF is now -111.59% below its all-time high of $809.10 million, reached on March 31, 2019.
Performance
UTHR quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$280.60M+$974.20M(+77.64%)Summary
- As of today (May 29, 2025), UTHR TTM cash flow from financing activities is -$280.60 million, with the most recent change of +$974.20 million (+77.64%) on March 31, 2025.
- Over the past year, UTHR TTM CFF has increased by +$847.90 million (+75.14%).
- UTHR TTM CFF is now -134.56% below its all-time high of $812.00 million, reached on June 30, 2019.
Performance
UTHR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
UTHR Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10000.0% | +91.2% | +75.1% |
| 3 y3 years | -2900.9% | -752.7% | -1284.0% |
| 5 y5 years | -305.3% | -86.8% | -13.1% |
UTHR Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1764.2% | at low | -269.0% | +91.2% | -305.7% | +78.0% |
| 5 y | 5-year | -305.3% | at low | -269.0% | +91.2% | -305.7% | +78.0% |
| alltime | all time | -305.3% | at low | -111.6% | +91.2% | -134.6% | +78.0% |
UTHR Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$93.80M(+25.6%) | -$280.60M(-77.6%) |
| Dec 2024 | -$1.25B(>+9900.0%) | -$74.70M(+16.5%) | -$1.25B(-1.4%) |
| Sep 2024 | - | -$64.10M(+33.5%) | -$1.27B(+6.0%) |
| Jun 2024 | - | -$48.00M(-95.5%) | -$1.20B(+6.4%) |
| Mar 2024 | - | -$1.07B(+1050.9%) | -$1.13B(+9383.2%) |
| Dec 2023 | -$11.90M(-115.8%) | -$92.80M(-1321.1%) | -$11.90M(-108.7%) |
| Sep 2023 | - | $7.60M(-69.2%) | $136.40M(+0.4%) |
| Jun 2023 | - | $24.70M(-49.2%) | $135.80M(+0.6%) |
| Mar 2023 | - | $48.60M(-12.4%) | $135.00M(+79.0%) |
| Dec 2022 | $75.40M(+68.3%) | $55.50M(+692.9%) | $75.40M(+175.2%) |
| Sep 2022 | - | $7.00M(-70.7%) | $27.40M(-25.9%) |
| Jun 2022 | - | $23.90M(-317.3%) | $37.00M(+56.1%) |
| Mar 2022 | - | -$11.00M(-246.7%) | $23.70M(-47.1%) |
| Dec 2021 | $44.80M(-365.1%) | $7.50M(-54.8%) | $44.80M(+3.2%) |
| Sep 2021 | - | $16.60M(+56.6%) | $43.40M(+34.0%) |
| Jun 2021 | - | $10.60M(+5.0%) | $32.40M(-25.3%) |
| Mar 2021 | - | $10.10M(+65.6%) | $43.40M(-356.8%) |
| Dec 2020 | -$16.90M(-102.8%) | $6.10M(+8.9%) | -$16.90M(-90.2%) |
| Sep 2020 | - | $5.60M(-74.1%) | -$173.00M(-23.8%) |
| Jun 2020 | - | $21.60M(-143.0%) | -$226.90M(-8.5%) |
| Mar 2020 | - | -$50.20M(-66.5%) | -$248.10M(-140.6%) |
| Dec 2019 | $611.20M(+9601.6%) | -$150.00M(+210.6%) | $611.20M(-19.7%) |
| Sep 2019 | - | -$48.30M(<-9900.0%) | $761.30M(-6.2%) |
| Jun 2019 | - | $400.00K(-100.0%) | $812.00M(+0.9%) |
| Mar 2019 | - | $809.10M(>+9900.0%) | $804.80M(>+9900.0%) |
| Dec 2018 | $6.30M(-85.5%) | $100.00K(-95.8%) | $6.30M(-21.3%) |
| Sep 2018 | - | $2.40M(-135.3%) | $8.00M(-12.1%) |
| Jun 2018 | - | -$6.80M(-164.2%) | $9.10M(-53.3%) |
| Mar 2018 | - | $10.60M(+488.9%) | $19.50M(-55.0%) |
| Dec 2017 | $43.30M(-108.7%) | $1.80M(-48.6%) | $43.30M(-171.9%) |
| Sep 2017 | - | $3.50M(-2.8%) | -$60.20M(-69.3%) |
| Jun 2017 | - | $3.60M(-89.5%) | -$196.00M(-42.4%) |
| Mar 2017 | - | $34.40M(-133.8%) | -$340.10M(-31.7%) |
| Dec 2016 | -$497.70M(+11.3%) | -$101.70M(-23.1%) | -$497.70M(+21.4%) |
| Sep 2016 | - | -$132.30M(-5.8%) | -$409.80M(+28.3%) |
| Jun 2016 | - | -$140.50M(+14.0%) | -$319.40M(-24.8%) |
| Mar 2016 | - | -$123.20M(+792.8%) | -$424.60M(-5.0%) |
| Dec 2015 | -$447.00M(-22.5%) | -$13.80M(-67.1%) | -$447.00M(-33.5%) |
| Sep 2015 | - | -$41.90M(-82.9%) | -$672.54M(-4.4%) |
| Jun 2015 | - | -$245.70M(+68.8%) | -$703.22M(+9.8%) |
| Mar 2015 | - | -$145.60M(-39.2%) | -$640.28M(+11.0%) |
| Dec 2014 | -$576.60M(>+9900.0%) | -$239.34M(+229.8%) | -$576.60M(+75.6%) |
| Sep 2014 | - | -$72.58M(-60.3%) | -$328.37M(+36.0%) |
| Jun 2014 | - | -$182.76M(+123.1%) | -$241.41M(+175.2%) |
| Mar 2014 | - | -$81.92M(-1021.9%) | -$87.73M(+1615.1%) |
| Dec 2013 | -$5.12M(-97.0%) | $8.89M(-38.2%) | -$5.12M(-92.0%) |
| Sep 2013 | - | $14.39M(-149.5%) | -$63.99M(-43.5%) |
| Jun 2013 | - | -$29.08M(-4290.6%) | -$113.33M(-33.6%) |
| Mar 2013 | - | $694.00K(-101.4%) | -$170.57M(+0.8%) |
| Dec 2012 | -$169.14M(-22.4%) | -$49.99M(+43.0%) | -$169.14M(-54.0%) |
| Sep 2012 | - | -$34.95M(-59.5%) | -$367.67M(+10.6%) |
| Jun 2012 | - | -$86.33M(-4156.9%) | -$332.29M(+42.1%) |
| Mar 2012 | - | $2.13M(-100.9%) | -$233.90M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$218.08M(-248.6%) | -$248.51M(<-9900.0%) | -$218.08M(-331.9%) |
| Sep 2011 | - | $421.00K(-96.5%) | $94.04M(-11.1%) |
| Jun 2011 | - | $12.06M(-32.8%) | $105.81M(-10.0%) |
| Mar 2011 | - | $17.95M(-71.8%) | $117.62M(-19.9%) |
| Dec 2010 | $146.76M(+302.3%) | $63.60M(+421.5%) | $146.76M(+56.3%) |
| Sep 2010 | - | $12.20M(-48.9%) | $93.88M(-5.9%) |
| Jun 2010 | - | $23.87M(-49.3%) | $99.73M(+20.9%) |
| Mar 2010 | - | $47.09M(+338.8%) | $82.52M(+126.2%) |
| Dec 2009 | $36.48M(-82.9%) | $10.73M(-40.5%) | $36.48M(-80.0%) |
| Sep 2009 | - | $18.04M(+170.9%) | $182.24M(-5.6%) |
| Jun 2009 | - | $6.66M(+538.6%) | $193.06M(-4.1%) |
| Mar 2009 | - | $1.04M(-99.3%) | $201.25M(-5.5%) |
| Dec 2008 | $213.03M(+920.3%) | $156.50M(+442.3%) | $213.03M(+86.9%) |
| Sep 2008 | - | $28.86M(+94.3%) | $113.98M(+18.7%) |
| Jun 2008 | - | $14.85M(+15.8%) | $96.04M(+6.2%) |
| Mar 2008 | - | $12.82M(-77.7%) | $90.43M(+333.1%) |
| Dec 2007 | $20.88M(-71.8%) | $57.46M(+426.5%) | $20.88M(-69.3%) |
| Sep 2007 | - | $10.91M(+18.1%) | $68.09M(+229.8%) |
| Jun 2007 | - | $9.24M(-116.3%) | $20.65M(+48.8%) |
| Mar 2007 | - | -$56.73M(-154.2%) | $13.87M(-81.3%) |
| Dec 2006 | $74.13M(+423.1%) | $104.67M(-386.5%) | $74.13M(-371.8%) |
| Sep 2006 | - | -$36.53M(-1584.6%) | -$27.28M(-290.3%) |
| Jun 2006 | - | $2.46M(-30.3%) | $14.33M(-6.0%) |
| Mar 2006 | - | $3.53M(+8.1%) | $15.24M(+7.6%) |
| Dec 2005 | $14.17M(+124.4%) | $3.27M(-35.6%) | $14.17M(+5.5%) |
| Sep 2005 | - | $5.07M(+50.7%) | $13.43M(+17.9%) |
| Jun 2005 | - | $3.37M(+36.9%) | $11.39M(+28.3%) |
| Mar 2005 | - | $2.46M(-2.7%) | $8.88M(+40.6%) |
| Dec 2004 | $6.32M(+214.7%) | $2.53M(-16.6%) | $6.32M(+176.2%) |
| Sep 2004 | - | $3.03M(+253.8%) | $2.29M(+418.6%) |
| Jun 2004 | - | $857.00K(-940.2%) | $441.00K(-76.9%) |
| Mar 2004 | - | -$102.00K(-93.2%) | $1.91M(-4.9%) |
| Dec 2003 | $2.01M(+984.9%) | -$1.50M(-226.5%) | $2.01M(-43.2%) |
| Sep 2003 | - | $1.19M(-49.0%) | $3.53M(+39.7%) |
| Jun 2003 | - | $2.32M(<-9900.0%) | $2.53M(+1152.0%) |
| Mar 2003 | - | -$3000.00(-112.0%) | $202.00K(+9.2%) |
| Dec 2002 | $185.00K(-106.4%) | $25.00K(-86.3%) | $185.00K(+35.7%) |
| Sep 2002 | - | $183.00K(-6200.0%) | $136.30K(-133.2%) |
| Jun 2002 | - | -$3000.00(-85.0%) | -$410.10K(-78.3%) |
| Mar 2002 | - | -$20.00K(-15.6%) | -$1.89M(-34.4%) |
| Dec 2001 | -$2.88M(-101.4%) | -$23.70K(-93.5%) | -$2.88M(-58.6%) |
| Sep 2001 | - | -$363.40K(-75.5%) | -$6.96M(-105.4%) |
| Jun 2001 | - | -$1.48M(+46.9%) | $127.82M(-2.1%) |
| Mar 2001 | - | -$1.01M(-75.4%) | $130.60M(-36.8%) |
| Dec 2000 | $206.61M(+248.4%) | -$4.10M(-103.1%) | $206.61M(-1.7%) |
| Sep 2000 | - | $134.41M(>+9900.0%) | $210.12M(+149.2%) |
| Jun 2000 | - | $1.30M(-98.3%) | $84.30M(-36.4%) |
| Mar 2000 | - | $75.00M(<-9900.0%) | $132.50M(+123.4%) |
| Dec 1999 | $59.30M(+159.0%) | -$600.00K(-107.0%) | $59.30M(-1.0%) |
| Sep 1999 | - | $8.60M(-82.6%) | $59.90M(+16.8%) |
| Jun 1999 | - | $49.50M(+2650.0%) | $51.30M(+2750.0%) |
| Mar 1999 | - | $1.80M | $1.80M |
| Dec 1998 | $22.90M | - | - |
FAQ
- What is United Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for United Therapeutics?
- What is United Therapeutics annual CFF year-on-year change?
- What is United Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for United Therapeutics?
- What is United Therapeutics quarterly CFF year-on-year change?
- What is United Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for United Therapeutics?
- What is United Therapeutics TTM CFF year-on-year change?
What is United Therapeutics annual cash flow from financing activities?
The current annual CFF of UTHR is -$1.25B
What is the all time high annual CFF for United Therapeutics?
United Therapeutics all-time high annual cash flow from financing activities is $611.20M
What is United Therapeutics annual CFF year-on-year change?
Over the past year, UTHR annual cash flow from financing activities has changed by -$1.24B (-10444.54%)
What is United Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of UTHR is -$93.80M
What is the all time high quarterly CFF for United Therapeutics?
United Therapeutics all-time high quarterly cash flow from financing activities is $809.10M
What is United Therapeutics quarterly CFF year-on-year change?
Over the past year, UTHR quarterly cash flow from financing activities has changed by +$974.20M (+91.22%)
What is United Therapeutics TTM cash flow from financing activities?
The current TTM CFF of UTHR is -$280.60M
What is the all time high TTM CFF for United Therapeutics?
United Therapeutics all-time high TTM cash flow from financing activities is $812.00M
What is United Therapeutics TTM CFF year-on-year change?
Over the past year, UTHR TTM cash flow from financing activities has changed by +$847.90M (+75.14%)